期刊文献+

血管内皮生长因子抑制剂结合活性试验两种结果分析方法比较

Comparison of Two Methods for Analyzing the Results of Vascular Endothelial Growth Factor Inhibitors Binding Activity Assays
下载PDF
导出
摘要 目的:对血管内皮生长因子抑制剂(VEGF Trap)结合活性试验两种结果分析方法进行比较,以考察两者的差异。方法:采用固定剂量的VEGF与系列稀释的VEGF Trap处理之后,检测未结合的VEGF的量,分别以未结合的VEGF量对VEGF Trap浓度梯度和未结合的VEGF检测板的OD值对VEGF Trap浓度梯度进行四参数方程拟合,两种方法计算该产品的结合活性。结果:两种方法均满足试验有效性条件,且血管内皮生长因子抑制剂供试品和标准品的半数抑制浓度(IC50)均分别为3.68和3.6pmoL·L-1,供试品的结合活性为102%。结论:证明了两种分析方法得到的结果完全一致。为同类产品结合活性计算方法的选择提供借鉴。 Objective: To compare the two methods for analyzing the results of vascular endothelial growth factor inhibitors binding activity assays. Methods: After a fixed amount of VEGF was applied to serially dilute VEGF Trap, the amount of unbound VEGF was detected. The two methods were used to calculate the binding activity of the products. One was the four-parameter equation fitting of the concentration gradient of VEGF Trap with the unbound VEGF amount, and the other was the four-parameter equation fitting of the concentration gradient of VEGF Trap with the OD value of the unbound VEGF detection plate. Results: Both methods met the test validity conditions, and the half inhibitory concentration(IC50) of the vascular endothelial growth factor inhibitors’ tested samples and the standard substance was 3.68 and 3.6 pmoL·L-1 respectively. The binding activity of the tested samples was 102%. Conclusion: The results obtained by the two methods are identical,which provide references for selecting methods for calculating the binding activity of similar products.
作者 毕华 李永红 范文红 陶磊 裴德宁 丁有学 饶春明 Bi Hua;Li Yonghong;Fan Wenhong;Tao Lei;Pei Dening;Ding Youxue;Rao Chunming(National Institutes for Food and Drug Control, Beijing 100050, China)
出处 《中国药事》 CAS 2019年第7期813-818,共6页 Chinese Pharmaceutical Affairs
关键词 血管内皮生长因子抑制剂 结合活性 半数抑制浓度 四参数方程 vascular endothelial growth factor inhibitors binding activity half inhibitory concentration fourparameter equation
  • 相关文献

参考文献5

二级参考文献40

  • 1郭杰标,郭锐,刘艳华.以抗体竞争结合抗原测定单抗亲和力常数的研究[J].南方医科大学学报,2006,26(7):1057-1059. 被引量:9
  • 2陈川(综述),俞德超(审阅),滕理送(审阅).以VEGF/VEGFR为靶点的抗肿瘤药物的研究进展[J].中国肿瘤生物治疗杂志,2007,14(3):291-295. 被引量:25
  • 3Gomez-Manzano C, Holash J, Fueyo J, et al. VEGF Trap induces antiglioma effect at different stages of disease [J]. Neuro Oncol, 2008, 10 (6): 940-945.
  • 4Barakat MR, Kaiser PK. VEGF inhibitors for the treatment of neovascular age-related macular degeneration [J]. Expert Opin Investig Drugs, 2009, 18 (5): 637-646.
  • 5Tremolada G, Lattanzio R, Mazzolari G, et al. The therapeutic potential of VEGF inhibition in diabetic microvascular complications [J]. Am J Cardiovasc Drugs, 2007, 7 (6): 393-398.
  • 6Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects [J]. Proc Natl Acad Sci USA, 2002, 99 (17): 11393-1398.
  • 7Stewart MW, Rosenfeld PJ. Predicted biological activity of intravitreal VEGF Trap [J]. Br J Ophthalmol, 2008, 92 (5): 667-668.
  • 8Verheul HM, Hammers H, Van Erp K, et al. Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model [J]. Clin Cancer Res, 2007, 13 ( 14): 4201-4208.
  • 9Lau SC, Rosa DD, Jayson G. Technology evaluation: VEGF Trap (cancer) , Regeneron/ sanofi - aventis. Curt Opin Mol Ther , 2005,7 (5) :493.
  • 10Holash J, Davis S, Papadopoulos N, et al. VEGF - Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A, 2002,99 (17) :11393.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部